| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/07/2008 | EP1917246A1 Benzoquinazoline derivatives and their use in treating bone disorders |
| 05/07/2008 | EP1917245A1 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors |
| 05/07/2008 | EP1917244A2 Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors |
| 05/07/2008 | EP1917242A1 Azabicyclo [3.1.0]hexylphenyl derivatives as modulators of dopamine d3 receptors |
| 05/07/2008 | EP1917241A2 Bicyclic derivatives as p38 kinase inhibitors |
| 05/07/2008 | EP1917239A1 Fluoroprostaglandins nitroderivatives |
| 05/07/2008 | EP1917238A2 Sulfonamides |
| 05/07/2008 | EP1917233A1 Chemical compounds |
| 05/07/2008 | EP1917072A2 Vitamin formulation |
| 05/07/2008 | EP1917071A1 Use of 25-hydroxy vitamin d3 to improve male animal fertility |
| 05/07/2008 | EP1917039A2 Methods and compositions for regenerating articular cartilage |
| 05/07/2008 | EP1917037A2 Peg-ifn alpha and ribavirin for hbv treatment |
| 05/07/2008 | EP1917036A2 Intermolecular association complex of a carrier and of an active principle |
| 05/07/2008 | EP1917035A2 Peroxide removal from drug delivery vehicle |
| 05/07/2008 | EP1917027A2 Cleavage of antifolate compounds |
| 05/07/2008 | EP1917018A2 New therapeutic use for a group of sulphated polysaccharides |
| 05/07/2008 | EP1917017A2 Treatment of amyotrophic lateral sclerosis with pyrimethamine and analogues 6 |
| 05/07/2008 | EP1917015A1 Novel 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid amides |
| 05/07/2008 | EP1917014A1 Neurorestoration with r(+) pramipexole |
| 05/07/2008 | EP1917013A1 Use of azabicyclo hexane derivatives |
| 05/07/2008 | EP1917012A1 Cell migration modulating compounds |
| 05/07/2008 | EP1917011A1 Combinations comprising dmxaa for the treatment of cancer |
| 05/07/2008 | EP1917010A2 Compositions and methods for treating vascular, autoimmune and inflammatory diseases |
| 05/07/2008 | EP1917009A2 Carbamate compounds for use in treating neurodegenerative disorders |
| 05/07/2008 | EP1917008A2 Use of soluble guanylate cyclase for the treatment of raynaud's phenomenon |
| 05/07/2008 | EP1917007A2 Inhibitors of anorexic lipid hydrolysis for the treatment of eating disorders |
| 05/07/2008 | EP1917006A2 Use of inhibitors of n-methyl transferases for the therapy of parkinson's disease |
| 05/07/2008 | EP1917000A2 Sustained release pharmaceutical compositions for highly water soluble drugs |
| 05/07/2008 | EP1916996A2 Production of an oxaliplatin mixture and a container and a container set for said mixture |
| 05/07/2008 | EP1916995A1 Ph-controlled pulsatile delivery system, methods for preparation and use thereof |
| 05/07/2008 | EP1916994A2 Manufacturing of quick release pharmaceutical composition of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention |
| 05/07/2008 | EP1916908A1 Phosphorylated glucomannane polysaccharides containing 1-6 and 1-2 linkages increase weight gain in poultry |
| 05/07/2008 | EP1916896A2 Non-steroidal antiandrogens |
| 05/07/2008 | EP1761519B1 Indole derivatives as histamine receptor antagonists |
| 05/07/2008 | EP1735295B1 Antiinflammatory lactones |
| 05/07/2008 | EP1725553B1 Tetrahydropyridoindole derivatives |
| 05/07/2008 | EP1722795B1 Piperidinyl prostaglandin e analogs |
| 05/07/2008 | EP1720849B1 Pyranone derivatives useful for treating cancer |
| 05/07/2008 | EP1688409B1 Vitamin d-derived monohalogenovinyl compounds |
| 05/07/2008 | EP1670902A4 METHOD AND COMPOSITION FOR ENHANCING i IN VITRO /i EMBRYO DEVELOPMENT BY SUPPLEMENTING CULTURE MEDIUM WITH PROSTAGLANDIN OR A PROSTAGLANDIN ANALOG |
| 05/07/2008 | EP1658056B1 Tablet containing 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]- methyl}-1-methyl-1h-benzimidazolo-5-carbonyl)-pyridino-2-yl- amino]-ethyl propionate or the salts thereof |
| 05/07/2008 | EP1651176A4 Antimicrobial compositons containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof |
| 05/07/2008 | EP1644318B1 Method for synthesizing ceramide-type compounds |
| 05/07/2008 | EP1628971B1 TRIAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 05/07/2008 | EP1623740B1 Pharmaceutical composition and method for the treatment and prevention of prostatic hyperplasia and prostatitis using roystonea regia (royal palm) fruits |
| 05/07/2008 | EP1608627B1 Bicyclic anilide spirohydantoin cgrp receptor antagonists |
| 05/07/2008 | EP1603880B1 Quinolinone/benzoxazinone derivatives and uses thereof |
| 05/07/2008 | EP1603874B1 G-lactam derivatives as prostaglandin agonists |
| 05/07/2008 | EP1601670B1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 05/07/2008 | EP1592680B1 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors |
| 05/07/2008 | EP1592446B1 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 05/07/2008 | EP1575963B1 Anti-angiogenetic therapeutic agents |
| 05/07/2008 | EP1558606A4 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors |
| 05/07/2008 | EP1558600B1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/07/2008 | EP1539751B1 Process for the preparation of imidazo(1,2-a)pyridine-3-acetamides |
| 05/07/2008 | EP1528931B1 Dipeptidyl peptidase iv inhibitors for decreasing the rate of chronic weight gain |
| 05/07/2008 | EP1513588B1 Use of new etonogestrel esters |
| 05/07/2008 | EP1509250B1 Methods compositions and articles of manufacture for modulating bone growth |
| 05/07/2008 | EP1509216B1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol |
| 05/07/2008 | EP1485051B1 Method of administering buprenorphine to treat depression |
| 05/07/2008 | EP1483285B1 INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME |
| 05/07/2008 | EP1480951B1 Synthesis of indole thiazole compounds as ligands for the ah receptor |
| 05/07/2008 | EP1460969B1 Prevention and treatment of androgen-deprivation induced osteoporosis |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | EP1434792B1 Peptidyl ketones as inhibitors of dpiv |
| 05/07/2008 | EP1417308B1 Human protooncogene kg-20 and protein encoded therein |
| 05/07/2008 | EP1411984B1 Combination medicament for treatment of neoplastic diseases which contains cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
| 05/07/2008 | EP1405848B1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 05/07/2008 | EP1395269B1 Lipoteichoic acid from lactic acid bacteria for use as medicament and in the treatment of bacterial diseases |
| 05/07/2008 | EP1392338B1 Herbal drug composition for cartilage protection |
| 05/07/2008 | EP1390347B1 Pyrrolidine ester derivatives with oxytocin modulating activity |
| 05/07/2008 | EP1383774B1 Dihydroimidazo¬4,5-e indole and 7h-pyrrolo¬3,2-f quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 05/07/2008 | EP1365768B1 Use of er-beta selective antagonists as contraceptives |
| 05/07/2008 | EP1364026B1 Human g protein-coupled receptor |
| 05/07/2008 | EP1347981B1 Condensed purine derivatives as a 1 adenosine receptor antagonists |
| 05/07/2008 | EP1339409B1 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 05/07/2008 | EP1328275B1 Substituted 4,5-dihydro-1,2,4-triazin-3-ones, 1,2,4-triazin-3-ones, and their use as fungicides and insecticides |
| 05/07/2008 | EP1299381B1 Substituted quinazoline derivatives and their use as inhibitors |
| 05/07/2008 | EP1250325B1 Phenanthridine-n-oxides |
| 05/07/2008 | EP1235916B1 ISOLATED POLYNUCLEOTIDES HAVING A REDUCED CONTENT OF 5'CpG3' EPIGENETIC CONTROL MOTIFS AND USES THEREOF |
| 05/07/2008 | EP1049707B1 Ustilipides, method for the production and the use thereof |
| 05/07/2008 | EP1020458B1 Optically active 1,4-benzodioxine-2-carboxylic acid derivatives and process for producing the same |
| 05/07/2008 | EP1015470A4 Composition and method for delivery of nucleic acids |
| 05/07/2008 | EP0991758B1 Smad6 and uses thereof |
| 05/07/2008 | EP0906106B1 Prevention and treatment of colonic adenoma or colonic microadenoma by 6-fluoroursodeoxycholic acid (6-fudca) |
| 05/07/2008 | CN101175861A Method |
| 05/07/2008 | CN101175769A Methods and compositions for modulating vascular integrity |
| 05/07/2008 | CN101175763A Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer |
| 05/07/2008 | CN101175762A Sucrose-6-ester chlorination by co-addition of chlorination reagent |
| 05/07/2008 | CN101175760A 39-desmethoxy derivatives of rapamycin |
| 05/07/2008 | CN101175759A Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 05/07/2008 | CN101175758A Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide |
| 05/07/2008 | CN101175757A Synthesis and purification of pteroic acid and conjugates thereof |
| 05/07/2008 | CN101175756A Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring |
| 05/07/2008 | CN101175755A N- [3- (1-amin0-5, 6, 7, 8-tetrahydro-2 , 4, 4b-triazafluoren-9-yl)-phenyl] benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase |
| 05/07/2008 | CN101175754A Novel tetrahydro-1h-pyrido [4,3-b] indole derivatives as cb1' receptor ligands |
| 05/07/2008 | CN101175753A Compounds and compositions as protein kinase inhibitors |
| 05/07/2008 | CN101175752A Polymorphic forms of (s)- tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate |
| 05/07/2008 | CN101175751A Crystal of indole derivative having piperidine ring and process for production thereof |
| 05/07/2008 | CN101175748A N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |